Donna Marron is Associate Director, Adverse Experience Reporting in Worldwide Product Safety & Epidemiology at Merck Research Laboratories, where she leads the teams responsible for the endocrine and metabolic programs including Fosamax®, Proscar®, Propecia®, Mevacor®, Zocor®, and Zetia™. Previously, she worked in the Worldwide Product Labeling department for 8 years where she held positions of increasing responsibility, most recently as Associate Director. Also during her career at Merck, Ms. Marron worked as an Adverse Experience Reporting Coordinator in Worldwide Product Safety and Epidemiology, and as a Staff Biologist in Safety Assessment. Earlier, she worked at Rorer Pharmaceuticals as a Pathology Research Assistant in Drug Safety and at Temple’s School of Medicine as a Research Assistant in Anatomy. She received a BS in Biology from Penn State and an MS in QA/RA from Temple.

Return to Faculty Home